Sumitomo Chemical may be considered a prime core holding candidate in the chemical sector. Its shift from bulk to fine chemicals, the development of new battery and electronic materials, and growth strategies in agrochemicals should support peak profits and cash flow through FY20.
We estimate that OP will drop by 64% in FY19 at subsidiary Sumitomo Dainippon Pharma (SDP, 4506) when antipsychotic drug Latuda goes off patent. We expect this event to lower Sumitomo Chemical’s OP by 11.1%, but NP by only 3.0%. For details on SDP’s strategy, please see our detailed April 12, 2017 report, ‘SDP (4506) – Engineering a Recovery, Never as Easy as Falling off a Cliff’.
Key Points
Sumitomo Chemical is a chemical manufacturing company. Co.'s business is comprised of 5 sectors: Petrochemicals & Plastics Sector, Energy & Functional Materials Sector, IT-related Chemicals Sector, Health & Crop Sciences Sector, Pharmaceuticals Sector and Others. Co. is engaged in the manufacture and sale of inorganic and organic chemicals, synthetic fiber materials, metal acrylate, alumina and aluminum products, petrochemical, synthetic resin and rubber products, optical goods, color filters, materials for semiconductors, electronic materials, agrochemicals, fertilizers, agricultural materials, pesticide, dietary additives, pharmaceuticals and radioactive diagnostic products.
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.